DBDesiree F. Baaleman

Desiree F. Baaleman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Desiree F. Baaleman has a total of 64 co-authors. Here are the top co-authors by number of shared publications:

  • Marc A. Benninga

    Department of Pediatric Gastroenterology and Nutrition, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

    7 shared publications
  • Carlo Di Lorenzo

    Division of Gastroenterology, Hepatology, and Nutrition Nationwide Children’s Hospital Columbus OH

    6 shared publications
  • Desale Yacob

    Division of Gastroenterology, Hepatology, and Nutrition Nationwide Children’s Hospital Columbus OH

    6 shared publications
  • Marc Alexander Benninga

    Department of Pediatric Gastroenterology and Nutrition, Emma Children's Hospital, Amsterdam UMC University of Amsterdam Amsterdam the Netherlands

    5 shared publications
  • Ilan Jasper Nader Koppen

    Department of Pediatric Gastroenterology and Nutrition, Emma Children's Hospital, Amsterdam UMC University of Amsterdam Amsterdam the Netherlands

    4 shared publications
  • Karla H. Vaz

    Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics Nationwide Children’s Hospital Columbus OH USA

    4 shared publications

Latest Publications

  • Open Access

    Attitudes toward the use of complementary and alternative medicine in children with gastrointestinal symptoms, a multicenter survey study among parents and pediatricians

    by M.N. Bloem, D.F. Baaleman, I.J.N. Koppen, M.W. Bijlsma, A.M. Vlieger, J. Goede, F.B. Plötz, S.T.A Teklenburg-Roord, F. de Lorijn, M.A. Benninga

    Disorders of gut-brain interaction (DGBI) are common in children and often persist despite conventional treatments, leading families to seek complementary and alternative medicine (CAM). However, evidence for CAM in pediatric DGBI is scarce. This multicenter survey study assessed parents’ and pediatricians’ experiences with and attitudes toward CAM for children with gastrointestinal symptoms. Parents and pediatricians of children (0–18 years) with gastroesophageal reflux disease (GERD) and DGBI (infant colic (IC), functional abdominal pain, and functional constipation) from six Dutch hospitals were included. GERD diagnosis was based on international guidelines, DGBI on Rome IV criteria. Parental surveys addressed child health, medication, (reasons for) CAM use, and attitudes toward CAM research. Pediatricians’ surveys covered experiences and attitudes toward CAM for pediatric DGBI. A total of 677 parents (71%) and 76 pediatricians (79%) responded. Most patients had functional constipation (45%) or abdominal pain (41%), with 8% IC and 6% GERD. Seventy-one percent had symptoms for over a year; 58% used medication, and 49% reported side effects. Overall, 42% of patients used CAM, mainly manual therapies, homeopathy, and natural remedies. Predictors of CAM use included IC, longer symptom duration, higher household income, and positive parental CAM experience. Among pediatricians, 53% recommended CAM. Pediatricians with over 15 years’ experience were less likely to recommend CAM. Sixty-five percent of parents were willing to participate in CAM research. Conclusion: CAM use is common among children with DGBI or GERD, and over half of pediatricians have recommended CAM, underscoring the need for efficacy studies of frequently used CAM. What is Known: • Complementary and alternative medicine (CAM) is commonly used among pediatric patients with gastrointestinal symptoms but often excluded in evidence-based guidelines due to insufficient evidence. • Previous research has examined perspectives of patients and families, with limited insight into pediatricians’ recommendations. What is New: • In Dutch hospitals, 42% of children with infant colic, reflux, abdominal pain, or constipation used CAM. Most pediatricians (52.6%) recommended some CAM to these patients. • Predictors for CAM use include infant colic, longer symptom duration, positive parental CAM experience, and higher income; pediatricians with > 15 years’ experience were less likely to recommend CAM. Parental interest in CAM research is high (65%). Graphical Abstract The alternative text for this image may have been generated using AI.

  • Open Access

    Prevalence of functional defecation disorders in European children: A systematic review and meta‐analysis

    by Michelle N. Bloem, Desiree F. Baaleman, Nikhil Thapar, Stephen E. Roberts, Ilan J. N. Koppen, Marc A. Benninga

    Objectives: Functional defecation disorders (FDDs) are common among children worldwide. The prevalence of these disorders has not been clearly described in Europe. This study performed a systematic review and meta‐analysis on the prevalence of FDD in European children and assessed geographical, age, and sex distribution and associated factors.Methods: PubMed, Embase, Psycinfo, Cochrane Library, and Cinahl were searched from 1999 to July 2023. Included studies were (1) prospective or cross‐sectional studies of European population‐based samples; (2) reporting the prevalence of infant dyschezia (ID) according to Rome II, III, or IV criteria or functional constipation (FC) or functional non‐retentive fecal incontinence (FNRFI) according to Rome III or IV criteria; (3) aged 0–18 years; and (4) published in English, Dutch or Spanish. PRISMA guidelines for extracting data and assessing data quality were followed.Results: Twenty‐eight studies were included. Pooled prevalence was 6.9% (95% confidence interval [CI]: 3.1%–11.9%) for ID in infants 0–12 months (9 studies, n = 5611), 8.17% (95% CI: 6.33%–10.22%) for FC in children n = 35,189), 11.39% (95% CI: 9.34%–14.11%) for FC in children 4–18 years, and 0.24% (95% CI: 0.07%–0.49%) for FNRFI in children 4–18 years (7 studies, n = 16,873). No sex predominance was found for FC. FC prevalence did not differ significantly when diagnosed according to Rome III versus IV. FC prevalence differed between countries, with greatest rates in Italy, Germany, and Spain. No meta‐analysis could be performed on other factors associated with FDD.Conclusions: FDD is common in European children. Future longitudinal studies are needed to provide better insight into associated factors in pathogenesis.


  • Open Access

    Accuracy of transabdominal ultrasound to diagnose functional constipation and fecal impaction in children: a systematic review and meta-analysis

    by Johanna M. B. W. Vos, Michelle N. Bloem, Anna de Geus, Mariska M. G. Leeflang, René Spijker, Ilan J. N. Koppen, Desiree F. Baaleman, Marc A. Benninga

    Background: Functional constipation is common in children and accurate diagnostic methods are essential for early diagnosis and effective management. The diagnostic accuracy of transabdominal ultrasound to diagnose functional constipation is unclear. Objective: To evaluate the diagnostic accuracy of transverse rectal diameter measurement via transabdominal ultrasound in diagnosing children with functional constipation and in identifying fecal impaction. Materials and methods: Electronic databases were searched from inception to March 2023. Original studies investigating the diagnostic accuracy of measuring transverse rectal diameter via transabdominal ultrasound, including children with and without functional constipation, or with and without fecal impaction were included. Data extraction and quality assessment were performed independently by two reviewers. Results: Sixteen studies were included (n = 1,801 children, 0–17 years). Thirteen studies investigated the diagnostic accuracy for functional constipation, and five for fecal impaction. High risk of bias was found across the majority of studies mainly due to un-blinded case–control designs. Cut-off transverse rectal diameter values to diagnose functional constipation ranged from 2.4 cm to 3.8 cm. Meta-analysis (seven studies, n = 509 children) estimated mean sensitivity and specificity to diagnose functional constipation were 0.68 (95% confidence interval (CI) 0.55–0.78) and 0.81 (95% CI 0.71–0.88), respectively. Meta-analysis of diagnostic accuracy of identifying fecal impaction was not feasible. Studies reported a sensitivity and specificity ranging between 68–100% and 83–100%, respectively. Conclusion: Transabdominal ultrasound may be a valuable non-invasive diagnostic tool to diagnose functional constipation by measuring transverse rectal diameter and identifying fecal impaction in children. Heterogeneous study methods and lack of age-dependent normal values impair current clinical recommendations. Future research should focus on separating age groups and developing a standardized protocol. Graphical


  • Open Access

    What are Normal Defecation Patterns in Healthy Children up to Four Years of Age? A Systematic Review and Meta-Analysis

    by Desiree F. Baaleman, Carrie A.M. Wegh, Tessa J.M. de Leeuw, Faridi S. van Etten – Jamaludin, Elaine E. Vaughan, Margriet H.C. Schoterman, Clara Belzer, Hauke Smidt, Merit M. Tabbers, Marc A. Benninga, et al.


  • Open Access

    Long‐Term Outcomes of Antegrade Continence Enemas to Treat Constipation and Fecal Incontinence in Children

    by Desiree F. Baaleman, Mana H. M.D. Vriesman, Peter L. Lu, Marc A. M.D. Benninga, Marc A. Levitt, Richard J. Wood, Desale Yacob, Carlo Di Lorenzo, Ilan J.N. M.D. Koppen

    Objectives: The objective of this study is to investigate long‐term outcomes of antegrade continence enema (ACE) treatment in children with constipation or fecal incontinence.Methods: Prospective cohort study including pediatric patients with organic or functional defecation disorders who started ACE treatment. Data were collected at baseline and at follow‐up (FU) from 6 weeks until 60 months. We assessed parent and patient‐reported gastrointestinal health‐related quality of life (HRQoL) using the Pediatric Quality of Life Inventory Gastrointestinal Symptoms Module (PedsQL‐GI), gastrointestinal symptoms, adverse events, and patient satisfaction.Results: Thirty‐eight children were included (61% male, median age 7.7 years, interquartile range 5.5–12.2). Twenty‐two children (58%) were diagnosed with functional constipation (FC), 10 (26%) with an anorectal malformation, and 6 (16%) with Hirschsprung disease. FU questionnaires were completed by 22 children (58%) at 6 months, 16 children (42%) at 12 months, 20 children (53%) at 24 months, and 10 children (26%) at 36 months. PedsQL‐GI scores improved overall with a significant increase at 12‐ and 24‐month FU for children with FC and a significant increase in parent reported PedsQL‐GI score at 36‐month FU for children with organic causes. Minor adverse events, such as granulation tissue, were reported in one‐third of children, and 10% of children needed a surgical revision of their ACE. The majority of all parents and children reported that they would “probably” or “definitely” choose ACE again.Conclusion: ACE treatment is perceived positively by patients and parents and can lead to long‐term improvement in gastrointestinal HRQoL in children with organic or functional defecation disorders.


  • Open Access

    Accuracy of Anorectal Manometry to Detect the Rectoanal Inhibitory Reflex in Children

    by Desiree F. Baaleman, Samir Mishra, Ilan J.N. Koppen, Jac. M. Oors, Marc A. Benninga, Neetu Bali, Karla H. Vaz, Desale Yacob, Carlo Di Lorenzo, Peter L. Lu

    Objectives: Our objective was to investigate if there is a difference in the detection of the rectoanal inhibitory reflex (RAIR) when an anorectal manometry (ARM) is performed awake or under general anesthesia.Methods: A retrospective review of ARM studies was performed to identify children who had undergone ARMs both while awake and under general anesthesia. We compared ARM outcomes including the detection of the RAIR and anal canal resting pressure.Results: Thirty‐four children had received ARMs both while awake and under general anesthesia (53% female, median age at first ARM 7.5 years [range 3–18 years]). In 9 of 34 (26%) children the RAIR was solely identified during ARM under general anesthesia and not during ARM while awake. In 6 of 9 (66%) this was unrelated to the balloon volumes used during balloon inflations. In 4 of 34 (12%) children, assessment of the RAIR was inconclusive during ARM under general anesthesia due to too low, or loss of anal canal pressure. In 2 of those children, ARMs while awake showed presence of a RAIR. Anal canal resting pressures were higher during ARM while awake versus ARM under general anesthesia (median 70 [interquartile range, IQR 59–85] vs 46 mmHg [IQR 36–65] respectively, P < 0.001).Conclusions: General anesthesia may affect the detection of a RAIR in 2 ways. On the one hand, it may facilitate better visualization in children in whom a RAIR could not be visualized while awake. On the other hand, it may cause a loss of anal canal pressure resulting in an inconclusive test result.


  • Reply to

    by Desiree F. Baaleman, Carrie A.M. Wegh, Maxime T.A. Hoogveld, Marc A. Benninga, Ilan J.N. Koppen

  • Anal Botulinum Toxin in Children with Hirschsprung Disease and Functional Constipation: A Prospective Cohort study

    by Desiree F. Baaleman, Alexandra Hallagan, Devin R. Halleran, Danielle K. Orsagh-Yentis, Marc A. Levitt, Richard J. Wood, Marc A. Benninga, Neetu Bali, Karla H. Vaz, Desale Yacob, et al.

    Introduction Anal sphincter botulinum toxin injections (BTIs) are used in the treatment of children with severe defecation disorders, including Hirschsprung disease (HD) and functional constipation (FC). Our objective was to evaluate the outcomes of BTI in these children. Materials and Methods We performed a prospective cohort study of children undergoing BTI from July 2018 to December 2018. We recorded perceived effect of the BTI, including effectiveness ranging from 0 (not at all effective) to 4 (extremely effective). In addition, we recorded symptoms and the Cleveland Clinic Constipation Score (CCCS). Data were collected at baseline and at 2 weeks, 2 months, and 4 months post-injection. Results Forty-two children (HD = 25, FC = 17) were included in the study (median age 4.3 years, IQR 2.4–7.2, 52% male). Twenty-two (88%) children with HD and eight (47%) children with FC had previously undergone a BTI. BTIs were perceived effective in 16 (76%) and 12 (71%) children with HD and eight (47%) and seven (47%) children with FC at 2-week and 2-month follow-up, respectively. Effectiveness was not rated differently between groups except at the 2-month follow-up, when patients with HD rated the BTI more effective compared to those with FC (median 2 [HD] vs. median 1 [FC], p = 0.022). Over the course of the study, 17/39 (44%) children reported self-limiting adverse effects such as fecal incontinence and pain at the injection site. Conclusion Anal sphincter BTIs can be effective in the treatment of constipation in both HD and FC patients.


  • Open Access

    Transanal Irrigation in Children

    by Desiree F. Baaleman, Carrie A. M. Wegh, Maxime T. A. Hoogveld, Marc A. Benninga, Ilan J. N. Koppen

    Objectives: To investigate the clinical effectiveness and patient experience of transanal irrigation (TAI) in children with constipation or fecal incontinence.Methods: Combined retrospective and cross‐sectional study including pediatric patients who used a Navina TAI system. We retrospectively collected baseline characteristics and data on treatment success at 1‐ and 6‐month follow‐up (FU). Treatment success was defined as defecating at least 3 times per week and having less than 1 episode of fecal incontinence per week. We cross‐sectionally assessed health‐related quality of life (HRQoL), treatment adherence, treatment satisfaction (Treatment Satisfaction Questionnaire for Medication [TSQM]), illness perceptions, medication beliefs, and patient empowerment with validated questionnaires.Results: Thirty‐four patients were included (median age at start TAI: 11 years old [range, 6–18]), 32 in the retrospective review, and 26 in the cross‐sectional survey (median of 3 years after initiation). Most patients were diagnosed with functional constipation (n = 26; 76%) or a neurogenic bowel disorder (n = 6; 18%). Treatment success rates significantly improved at each FU compared with baseline (baseline: 4/25 [16%]; 1‐month FU: 12/16 [75%], P = 0.008; 6‐month FU: 11/18 [61%], P = 0.016; cross‐sectional FU: 13/26 [50%], P = 0.008). HRQoL scores were high (PedsQL median, 73 [IQR, 54–85]). Adherence (defined as Medication Adherence Report Scale [MARS] ≥ 23) was low (36%), whereas TSQM effectiveness scores were high (median, 69 [IQR, 47–86]). The majority of children (61%) reported an increase in independence since TAI treatment. Patient empowerment (GYPES) levels were similar to those reported in children with other chronic conditions.Conclusions: TAI with a Navina system is an effective bowel management system for children with intractable constipation or fecal incontinence.


  • Open Access

    Hypnosis to Reduce Distress in Children Undergoing Anorectal Manometry: A Randomized Controlled Pilot Trial

    by Desiree F Baaleman, Mana H Vriesman, Ilan J N Koppen, Kim M Osborne, Marc A Benninga, Miguel Saps, Desale Yacob, Peter L Lu, Frederick W Woodley, Carlo Di Lorenzo

    Desiree F Baaleman, Mana H Vriesman, Ilan J N Koppen, Kim M Osborne, Marc A Benninga, Miguel Saps, Desale Yacob, Peter L Lu, Frederick W Woodley, and Carlo Di Lorenzo. J Neurogastroenterol Motil 2022;28:312-9. https://doi.org/10.5056/jnm20274